Minerva Neurosciences, Inc. (NASDAQ: NERV) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Minerva Neurosciences (NERV) Upgraded to Buy: What Does It Mean for the Stock? [Yahoo! Finance]
Minerva Neurosciences, Inc. (NASDAQ: NERV) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Minerva Neurosciences, Inc. (NASDAQ: NERV) had its price target lowered by analysts at HC Wainwright from $11.00 to $7.00. They now have a "neutral" rating on the stock.
Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business Updates [Yahoo! Finance]